These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7705677)

  • 1. Activated (HLA-DR+) T-lymphocyte subsets in cervical carcinoma and effects of radiotherapy and immunotherapy with sizofiran on cell-mediated immunity and survival.
    Miyazaki K; Mizutani H; Katabuchi H; Fukuma K; Fujisaki S; Okamura H
    Gynecol Oncol; 1995 Mar; 56(3):412-20. PubMed ID: 7705677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Electron microscopic and immunological studies concerning the effect on the antitumor activity of sizofiran (SPG) combined with radiotherapy for cervical cancer].
    Hasegawa K; Nishimura R; Kinugasa M; Okamura M; Kimura A; Ohtsu F; Takeuchi K; Mizuhira V
    Nihon Gan Chiryo Gakkai Shi; 1990 Oct; 25(10):2549-61. PubMed ID: 2124607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of blood transfusion during radiotherapy on the immune function of patients with cancer of the uterine cervix: role of interleukin-10.
    Santin AD; Bellone S; Palmieri M; Bossini B; Dunn D; Roman JJ; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2002 Dec; 54(5):1345-55. PubMed ID: 12459356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic Monitoring of T-Lymphocyte Subsets and Hla-Dr-Positive Monocytes in Kidney Transplant Recipients: A Prospective, Observational Cohort Study.
    Cho JH; Yoon YD; Jang HM; Kwon E; Jung HY; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Won DI; Kim CD
    Medicine (Baltimore); 2015 Nov; 94(44):e1902. PubMed ID: 26554788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The study on the immunological effect of sizofilan combined with radiotherapy in patients with uterine cervical cancer].
    Sekiguchi I; Suzuki M; Izumi A; Aida I; Tamada T
    Nihon Gan Chiryo Gakkai Shi; 1990 Nov; 25(11):2659-64. PubMed ID: 2126027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improvement in the effects of radiation therapy with BRM].
    Inomata T; Ogawa Y; Nishioka A; Maeda T; Seguchi H
    Gan No Rinsho; 1990 Oct; 36(13):2278-85. PubMed ID: 2123503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
    Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
    Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
    Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The cytoimmunological effect of concomitant use of sizofiran (SPG) on advanced uterine cervical cancer treated with radiation].
    Iwanari O; Miyako J; Ryuko K; Date Y; Moriyama M; Moriyama M; Kijima S; Yoshino N; Kitao M
    Nihon Gan Chiryo Gakkai Shi; 1989 Oct; 24(10):2355-61. PubMed ID: 2533231
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of sizofilan as assistant immunotherapy in treatment of head and neck cancer.
    Kimura Y; Tojima H; Fukase S; Takeda K
    Acta Otolaryngol Suppl; 1994; 511():192-5. PubMed ID: 7911266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological modulation of lymphocyte subpopulation in cervical cancer tissue by sizofiran and OK-432.
    Gorai I; Yanagibashi T; Minaguchi H
    Gynecol Oncol; 1992 Feb; 44(2):137-46. PubMed ID: 1371977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
    Gold JE; Zachary DT; Osband ME
    Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [T-lymphocyte immune in HIV-infected people and AIDS patients in China].
    Li T; Qiu Z; Wang A; Sheng R
    Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1391-5. PubMed ID: 12509921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmenting effect of sizofiran on the immunofunction of regional lymph nodes in cervical cancer.
    Shimizu Y; Hasumi K; Masubuchi K
    Cancer; 1992 Mar; 69(5):1184-94. PubMed ID: 1739919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of concurrent cisplatinum administration during radiotherapy vs. radiotherapy alone on the immune function of patients with cancer of the uterine cervix.
    Santin AD; Hermonat PL; Ravaggi A; Bellone S; Roman J; Pecorelli S; Cannon M; Parham GP
    Int J Radiat Oncol Biol Phys; 2000 Nov; 48(4):997-1006. PubMed ID: 11072156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of concomitant use of doxifluridine, radiotherapy and immunotherapy in patients with advanced cervical cancer.
    Yamamoto K; Noda K; Hatae M; Kudo T; Hasegawa K; Nishimura R; Honjo H; Yajima A; Sato S; Mizutani K; Yakushiji M; Terashima Y; Ochiai K; Sasaki H; Ozaki M
    Oncol Rep; 2001; 8(2):273-7. PubMed ID: 11182039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathogenetic and clinical significance of peripheral activated T-lymphocyte subsets in Basedow's disease].
    Wenjuan D; Shen G; Ye W
    Schweiz Med Wochenschr; 1992 May; 122(21):800-4. PubMed ID: 1604285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Change of T lymphocyte and its activated subsets in SARS patients].
    Yu XY; Zhang YC; Han CW; Wang P; Xue XJ; Cong YL
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Oct; 25(5):542-6. PubMed ID: 14650154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study on the changes of the T-lymphocyte subsets and their significance in influenza A (H1N1) virus patients].
    Zhang SP; Zhu ML; Yu JH; Wang Y; Lou GQ
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Jun; 24(3):181-3. PubMed ID: 21186520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.